FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308527173> ?p ?o ?g. }

• W4308527173 abstract "Abstract Background To date, the treatment success rate of Multidrug-resistant tuberculosis (MDR-TB) is low. The prolonged treatment course and expensive second-line anti-tuberculosis drugs (SLDs) for treating MDR-TB could lead to heavy financial expenditure. This economic barrier might result in poor adherence, lost to follow-up and treatment failure. Therefore, provision of financial support might improve treatment outcomes of MDR-TB. This study investigated the association between a subsidy policy and treatment outcomes of MDR-TB patients. Methods In this population-based, retrospective study, demographic, clinical characteristics, and the drug susceptibility profiles of all registered MDR-TB patients between 2011 and 2019 in Shanghai, China were collected. In total, 865 of 1016 patients were eligible for analysis, among which 70.6% (611/865) had treatment success. Information on the subsidies for MDR-TB treatment, which was in addition to the basic health insurance, were routinely recorded by the end of December 2021. Multivariate logistic regression adjusted for potential confounders was performed to evaluate the association between the situation of subsidies and treatment outcomes by estimating odds ratios (ORs) and 95% confidence intervals (CIs). The effect of greater/less subsidies on outcomes was further assessed using the median amount of financial support as cut-off points. Results During the study period, 74.1% (641/856) patients received subsidies for MDR-TB treatment. The median subsidies received across the treatment course was 15026 (Interquartile range, IQR, 7107–36001) Chinese Yuan (CNY), of which the reimbursement for SLDs were the major components. Those who had treatment success received significantly more subsidies (median, 17836 CNY) compared with patients with adverse outcomes (9794 CNY, P < 0.001). Benefiting from the subsidy policy was positively associated with treatment success, with an adjusted odds ratio (OR) equal to 2.95 (95% confidence interval [CI], 2.03–4.28). Among 641 patients who received subsidies, the OR comparing those with greater and less reimbursement was 1.74 (95% CI, 1.16–2.61). Additional adjustment for baseline drug-resistance did not alter these results. Conclusions Financial support was positively associated with better treatment outcomes among MDR-TB patients. Results in this study call for further financial assistance to facilitate appropriate medical care and to improve treatment outcomes of MDR-TB." @default.
• W4308527173 created "2022-11-12" @default.
• W4308527173 creator A5004363711 @default.
• W4308527173 creator A5010092575 @default.
• W4308527173 creator A5023596296 @default.
• W4308527173 creator A5028667300 @default.
• W4308527173 creator A5044544424 @default.
• W4308527173 creator A5048379858 @default.
• W4308527173 creator A5051882120 @default.
• W4308527173 creator A5085462851 @default.
• W4308527173 date "2022-11-08" @default.
• W4308527173 modified "2023-10-12" @default.
• W4308527173 title "Impact of financial support on treatment outcomes of multidrug-resistant tuberculosis: a population-based, retrospective cohort study in China" @default.
• W4308527173 cites W1975654711 @default.
• W4308527173 cites W2004143136 @default.
• W4308527173 cites W2079483569 @default.
• W4308527173 cites W2130353817 @default.
• W4308527173 cites W2138699271 @default.
• W4308527173 cites W2140193283 @default.
• W4308527173 cites W2145037536 @default.
• W4308527173 cites W2337541451 @default.
• W4308527173 cites W2515305071 @default.
• W4308527173 cites W2589717236 @default.
• W4308527173 cites W2611026647 @default.
• W4308527173 cites W2789438386 @default.
• W4308527173 cites W2790671762 @default.
• W4308527173 cites W2851439851 @default.
• W4308527173 cites W2887664158 @default.
• W4308527173 cites W2912204556 @default.
• W4308527173 cites W2949143937 @default.
• W4308527173 cites W2995361147 @default.
• W4308527173 cites W3012216007 @default.
• W4308527173 cites W3033609190 @default.
• W4308527173 cites W3041246093 @default.
• W4308527173 cites W3046112730 @default.
• W4308527173 cites W3093311569 @default.
• W4308527173 cites W3155011555 @default.
• W4308527173 cites W3157171993 @default.
• W4308527173 cites W3170526386 @default.
• W4308527173 cites W4205234310 @default.
• W4308527173 cites W4225427434 @default.
• W4308527173 doi "https://doi.org/10.21203/rs.3.rs-2192240/v1" @default.
• W4308527173 hasPublicationYear "2022" @default.
• W4308527173 type Work @default.
• W4308527173 citedByCount "0" @default.
• W4308527173 crossrefType "posted-content" @default.
• W4308527173 hasAuthorship W4308527173A5004363711 @default.
• W4308527173 hasAuthorship W4308527173A5010092575 @default.
• W4308527173 hasAuthorship W4308527173A5023596296 @default.
• W4308527173 hasAuthorship W4308527173A5028667300 @default.
• W4308527173 hasAuthorship W4308527173A5044544424 @default.
• W4308527173 hasAuthorship W4308527173A5048379858 @default.
• W4308527173 hasAuthorship W4308527173A5051882120 @default.
• W4308527173 hasAuthorship W4308527173A5085462851 @default.
• W4308527173 hasBestOaLocation W43085271731 @default.
• W4308527173 hasConcept C119060515 @default.
• W4308527173 hasConcept C126322002 @default.
• W4308527173 hasConcept C142724271 @default.
• W4308527173 hasConcept C151956035 @default.
• W4308527173 hasConcept C156957248 @default.
• W4308527173 hasConcept C167135981 @default.
• W4308527173 hasConcept C2777025531 @default.
• W4308527173 hasConcept C2777107064 @default.
• W4308527173 hasConcept C2777975735 @default.
• W4308527173 hasConcept C2781069245 @default.
• W4308527173 hasConcept C2908647359 @default.
• W4308527173 hasConcept C44249647 @default.
• W4308527173 hasConcept C71924100 @default.
• W4308527173 hasConcept C99454951 @default.
• W4308527173 hasConceptScore W4308527173C119060515 @default.
• W4308527173 hasConceptScore W4308527173C126322002 @default.
• W4308527173 hasConceptScore W4308527173C142724271 @default.
• W4308527173 hasConceptScore W4308527173C151956035 @default.
• W4308527173 hasConceptScore W4308527173C156957248 @default.
• W4308527173 hasConceptScore W4308527173C167135981 @default.
• W4308527173 hasConceptScore W4308527173C2777025531 @default.
• W4308527173 hasConceptScore W4308527173C2777107064 @default.
• W4308527173 hasConceptScore W4308527173C2777975735 @default.
• W4308527173 hasConceptScore W4308527173C2781069245 @default.
• W4308527173 hasConceptScore W4308527173C2908647359 @default.
• W4308527173 hasConceptScore W4308527173C44249647 @default.
• W4308527173 hasConceptScore W4308527173C71924100 @default.
• W4308527173 hasConceptScore W4308527173C99454951 @default.
• W4308527173 hasLocation W43085271731 @default.
• W4308527173 hasOpenAccess W4308527173 @default.
• W4308527173 hasPrimaryLocation W43085271731 @default.
• W4308527173 hasRelatedWork W2018589250 @default.
• W4308527173 hasRelatedWork W2037611947 @default.
• W4308527173 hasRelatedWork W2335988042 @default.
• W4308527173 hasRelatedWork W2519173878 @default.
• W4308527173 hasRelatedWork W2906875615 @default.
• W4308527173 hasRelatedWork W3137102446 @default.
• W4308527173 hasRelatedWork W4281554690 @default.
• W4308527173 hasRelatedWork W4285601951 @default.
• W4308527173 hasRelatedWork W4292680240 @default.
• W4308527173 hasRelatedWork W4322739880 @default.
• W4308527173 isParatext "false" @default.
• W4308527173 isRetracted "false" @default.
• W4308527173 workType "article" @default.